Evidence map›Paper›PMID 35621990›Full record

ArticleDiabetes2022

Infant Mesenchymal Stem Cell Insulin Action Is Associated With Maternal Plasma Free Fatty Acids, Independent of Obesity Status: The Healthy Start Study.

Alec B Chaves, Donghai Zheng, Jonathan A Johnson, Bryan C Bergman, Zachary W Patinkin, Vincent Zaegel, Ericka M Biagioni, Polina Krassovskaia, Nicholas T Broskey, Linda E May and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Alec B ChavesHuman Performance Laboratory, Department of Kinesiology, East Carolina University, Greenville, NC.ORCID 0000-0002-3117-9256
Donghai ZhengHuman Performance Laboratory, Department of Kinesiology, East Carolina University, Greenville, NC.
Jonathan A JohnsonHuman Performance Laboratory, Department of Kinesiology, East Carolina University, Greenville, NC.
Bryan C BergmanDivision of Endocrinology, Metabolism, and Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO.ORCID 0000-0002-9561-1052
Zachary W PatinkinDepartment of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY.
Vincent ZaegelDepartment of Pediatrics, University of Colorado School of Medicine, Aurora, CO.
Ericka M BiagioniHuman Performance Laboratory, Department of Kinesiology, East Carolina University, Greenville, NC.
Polina KrassovskaiaHuman Performance Laboratory, Department of Kinesiology, East Carolina University, Greenville, NC.
Nicholas T BroskeyHuman Performance Laboratory, Department of Kinesiology, East Carolina University, Greenville, NC.ORCID 0000-0002-1197-5116
Linda E MayHuman Performance Laboratory, Department of Kinesiology, East Carolina University, Greenville, NC.
Dana DabeleaDepartment of Pediatrics, University of Colorado School of Medicine, Aurora, CO.
Joseph A HoumardHuman Performance Laboratory, Department of Kinesiology, East Carolina University, Greenville, NC.ORCID 0000-0003-3682-5410
Kristen E BoyleDepartment of Pediatrics, University of Colorado School of Medicine, Aurora, CO.ORCID 0000-0001-9689-3322
East Carolina University · USUniversity of Colorado Denver · USColorado School of Public Health · USUniversity of Colorado Anschutz Medical Campus · USUniversity of Rochester Medical Center · US

Funding

NIH Prior Approval Process ProfessionalUL1TR002535 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2018 to 2022
$51.1M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
PILOT STUDY--SUBSTRATE METABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTSP30DK048520 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Edward L Melanson · 1995 to 2026
$32.6M
Exploring the Fuel-Mediated Programming of Neonatal GrowthR01DK076648 · NIDDK · UNIVERSITY OF COLORADO DENVER/HSC DENVER · PI DABELEA, DANA · 2009 to 2018
$7.0M
The Early Life Exposome and Childhood Health - The Colorado Healthy Start 3 Cohort StudyUG3OD023248 · OD · UNIVERSITY OF COLORADO DENVER · PI BEKELMAN, TRACI ALLISON, DABELEA, DANA · 2016 to 2024
$5.9M
Epigenetic programming of infant mesenchymal stem cells: mechanisms for obesity and diabetes risk in humansR01DK117168 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI BOYLE, KRISTEN ELIZABETH · 2018 to 2022
$1.7M
NCATS NIH HHS UL1 TR001082NCATS NIH HHS UL1 TR002535NIDDK NIH HHS P30 DK048520NIDDK NIH HHS R01 DK076648NIDDK NIH HHS R01 DK117168NIH HHS UG3 OD023248
6 · The paper itself

Abstract

Preclinical rodent and nonhuman primate models investigating maternal obesity have highlighted the importance of the intrauterine environment in the development of insulin resistance in offspring; however, it remains unclear if these findings can be translated to humans. To investigate possible intrauterine effects in humans, we isolated mesenchymal stem cells (MSCs) from the umbilical cord tissue of infants born to mothers of normal weight or mothers with obesity. Insulin-stimulated glycogen storage was determined in MSCs undergoing myogenesis in vitro. There was no difference in insulin action based on maternal obesity. However, maternal free fatty acid (FFA) concentration, cord leptin, and intracellular triglyceride content were positively correlated with insulin action. Furthermore, MSCs from offspring born to mothers with elevated FFAs displayed elevated activation of the mTOR signaling pathway. Taken together, these data suggest that infants born to mothers with elevated lipid availability have greater insulin action in MSCs, which may indicate upregulation of growth and lipid storage pathways during periods of maternal overnutrition.

Indexed as

Mesenchymal Stem CellsPregnancy in ObesityAnimalsFatty Acids, NonesterifiedFemaleHumansInfantInsulinInsulin, Regular, HumanObesityPregnancyFatty Acids, NonesterifiedInsulinInsulin, Regular, Human

Identifiers

PMID35621990
PMCPMC9490356
OpenAlexW4281740806

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.